Annotation Detail

Information
Associated Genes
MAP2K1
Associated Variants
MAP2K1 MUTATION
MAP2K1 MUTATION
Associated Disease
Malignant neoplasm of stomach
Source Database
DisGeNET
Description
KRAS amplification was associated with worse clinical outcomes, and the KRAS gene mutation predicted sensitivity to the MEK1/2 inhibitor AZD6244 in gastric cancer cell lines.
Pubmed
24935174
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
6
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00081432561624091
Drugs